Tianshui Hospital of Traditional Chinese Medicine Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02728180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tianshui Hospital of Traditional Chinese Medicine

Active Ingredients

Drugs in Phase 4 Trials (1)

xingnaojing (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 4)

Ischemia (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1